MADISON HEIGHTS, Mich., April 26, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU) today announced that Chairman and Chief Executive Officer, Sean McDevitt, and Vice Chairman, Pat LaVecchia, will present at SEVEN, Noble Financial Capital Markets' Seventh Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, at 2:00pm EDT, Tuesday May 17, 2011.
At the time of the presentation, a live audio and high-definition video webcast of InfuSystem's presentation and a copy of the presentation materials will be available on the InfuSystem's web site, , in the Investors section, or through the Noble Financial websites: or . InfuSystem invites interested investors to watch the presentation and recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer to participate.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The company's stock is traded on the NYSE Amex under the symbol INFU.
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service investment banking boutique focused on small-cap, emerging growth companies. The company has offices in New York, Boston, New Jersey, St. Louis, and Boca Raton. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in late spring, featuring presenting companies from across North America and total attendance of close to 600. For more information:
CONTACT: INVESTOR CONTACT: Pat LaVecchia Vice Chairman [email protected] Tel: (800) 962-9656 MEDIA CONTACT: David Haar [email protected] Tel: (800) 962-9656
